Biomedical applications

Aaron leads his group in Bioinspired Molecular Interfaces in the Department of Pure and Applied Chemistry at the University of Strathclyde. He takes an interdisciplinary approach based on molecular engineering and biophysical chemistry to pioneer peptides and peptide-mimetic “peptoids” with precise molecular functionalities for antimicrobials, self-assembly, and biomedical applications. He also develops plant-based polyphenol-biopolymer composites as coatings and sustainable materials, and he frequently engages with industry in both consultancies and collaborative projects. Aaron obtained his PhD at the Max Planck Institute for Polymer Research, Germany, and postdoctoral training at Northwestern University, USA. His awards include an US NIH National Research Service Award and a Human Frontier Science Program (HFSP) Young Investigator award. Among various engagements, Aaron is Co-Director of the Strathclyde’s Leverhulme Doctoral School in Nature Inspired Acoustics responsible for materials development, and he serves as secretary of the Royal Society of Chemistry Glasgow and West of Scotland section.

The Luk Group, based at the University of Cardiff, aims to empower protein science and its applications, through (a) Protein labelling via biocatalysts, (b) Discovery of Peptide Binders, and (c) Enzyme catalysed bifunctional ligand synthesis.

Dr Alison Edwards is the Senior Lecturer in Pharmaceutical Chemistry at the Universities of Greenwich and Kent at Medway.

Anna is an Associate Professor (Senior Lecturer) in the Department of Chemistry at Imperial. Her research focuses on the development of peptides and small molecules to understand and perturb protein-protein interactions.

Dr Andrew Marsh has been making molecules for applications in supramolecular and biological systems since the last century. His current research interests include applications of guanosine quartets for delivery of potential therapeutics, inhibitors of RNA viruses and associated problems in medicinal chemistry.

The Lusby group has established itself as pioneers in the field of application-led supramolecular chemistry, developing methods in catalysis, biomedicine and magnetism. Professor Paul Lusby started his independent academic career as a Royal Society URF at the University of Edinburgh, where he now holds a personal chair in supramolecular chemistry.

Charlie McTernan is a Group Leader in the Physical Sciences at the Francis Crick Institute in London, and a Senior Lecturer at the Department of Chemistry at King's College London. He is a Supramolecular Chemist, investigating how Artificial Molecular Machines and Metal-Organic Capsules can be applied in Biomedical Science.

Peter is a synthetic organic chemist with a group focused on developing synthetic methodologies, and developing new foldamer motifs. The Knipe Group are particularly interested in precise control of conformation by non-covalent interactions, stereoelectronic effects and monomer structure.